These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16493928)

  • 1. [Stereopharmacology of carnitine].
    Spasov AA; IIezhitsa IN
    Ross Fiziol Zh Im I M Sechenova; 2005 Dec; 91(12):1469-80. PubMed ID: 16493928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative evaluation of the effects of carnitine stereoisomers and racemate on the cardio- and hemodynamics of rats on a carnitine-deficient diet].
    Spasov AA; Iezhitsa IN; Tiurenkov IN; Perfilova VN; Gurova NA; Kravchenko MS
    Vestn Ross Akad Med Nauk; 2006; (7):20-7. PubMed ID: 16924874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Carnitine: therapeutic applications of a conditionally-essential amino acid.
    Kelly GS
    Altern Med Rev; 1998 Oct; 3(5):345-60. PubMed ID: 9804680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of carnitine in cardiovascular disorders.
    Pepine CJ
    Clin Ther; 1991; 13(1):2-21; discussion 1. PubMed ID: 2029724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of L-carnitine.
    Evans AM; Fornasini G
    Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.
    Goa KL; Brogden RN
    Drugs; 1987 Jul; 34(1):1-24. PubMed ID: 3308409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine metabolism and deficit--when supplementation is necessary?
    Evangeliou A; Vlassopoulos D
    Curr Pharm Biotechnol; 2003 Jun; 4(3):211-9. PubMed ID: 12769764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of L-carnitine import into heart cells.
    Rigault C; Dias JV; Demarquoy J; Le Borgne F
    Biochimie; 2008 Mar; 90(3):542-6. PubMed ID: 17967426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carnitine deficiency].
    Schmidt-Sommerfeld E; Penn D
    Monatsschr Kinderheilkd; 1986 May; 134(5):224-31. PubMed ID: 3014317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis-related carnitine disorder and levocarnitine pharmacology.
    Evans A
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
    Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
    Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine in type 2 diabetes.
    Mingrone G
    Ann N Y Acad Sci; 2004 Nov; 1033():99-107. PubMed ID: 15591007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional absorption of L-carnitine after oral administration in rats: evaluation of absorption site and dose dependency.
    Matsuda K; Yuasa H; Watanabe J
    Biol Pharm Bull; 1998 Jul; 21(7):752-5. PubMed ID: 9703262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of carnitine biosynthesis and transport.
    El-Hattab AW; Scaglia F
    Mol Genet Metab; 2015 Nov; 116(3):107-12. PubMed ID: 26385306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamine-like substances L-carnitine and acetyl-L-carnitine: from biochemical studies to medicine].
    Kopelevich VM
    Ukr Biokhim Zh (1999); 2005; 77(4):30-50. PubMed ID: 16568602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.